Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL.2, 2012, Pages 13-20

  Toh, Sengwee ^a   García Rodríguez, Luis A ^b   Hernán, Miguel A ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Pharmacoepidemiology   (Spain)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Comparative effectiveness research; Confounding; Databases; Missing data; Pharmacoepidemiology; THIN

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMPARATIVE EFFECTIVENESS; DATA BASE; DATA PROCESSING; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; PRESCRIPTION; PRIORITY JOURNAL; SMOKING; UPPER GASTROINTESTINAL BLEEDING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MODELS, STATISTICAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN;

EID: 84860552743     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3248     Document Type: Article

References (46)

1. Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects-advantages and disadvantages. Nat Clin Pract Rheumatol 2007; 3: 725-732.
2. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005; 58: 323-337.
3. Andrade SE, Raebel MA, Boudreau D, et al. Chapter 12: Health maintenance organizations/health plans. In Pharmacoepidemiology (5th Edn), Strom BL, Kimmel SE, Hennessy S, (eds.). Wiley-Blackwell: Hoboken, NJ; 2012; 163-188.
4. Doebbeling BN, Wyant DK, McCoy KD, et al. Linked insurance-tumor registry database for health services research. Med Care 1999; 37: 1105-1115.
5. Bradley CJ, Given CW, Luo Z, et al. Medicaid, Medicare, and the Michigan Tumor Registry: a linkage strategy. Med Decis Making 2007; 27: 352-363.
6. Hammill BG, Hernandez AF, Peterson ED, et al. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J 2009; 157: 995-1000.
7. Douglas PS, Brennan JM, Anstrom KJ, et al. Clinical effectiveness of coronary stents in elderly persons: results from 262, 700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol 2009; 53: 1629-1641.
8. Piper JM, Ray WA, Griffin MR, et al. Methodological issues in evaluating expanded Medicaid coverage for pregnant women. Am J Epidemiol 1990; 132: 561-571.
9. Andrade SE, Davis RL, Cheetham TC, et al. Medication exposure in pregnancy risk evaluation program. Matern Child Health J 2011. DOI: 10.1007/s10995-011-0902-x
10. Lillard LA, Farmer MM. Linking Medicare and national survey data. Ann Intern Med 1997; 127: 691-695.
11. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 1995; 142: 1255-1264.
12. Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat 2007; 61: 79-90.
13. Faris PD, Ghali WA, Brant R, et al. Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses. J Clin Epidemiol 2002; 55: 184-191.
14. Rostom A, Muir K, Dube C, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007; 5: 818-828, 828 e811-815; quiz 768.
15. Chen YF, Jobanputra P, Barton P, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008; 12: 1-278, iii.
16. Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16: 393-401.
17. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004; 12: 171-177.
18. Toh S, García Rodríguez LA, Hernán MA. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf 2011; 20: 849-857.
19. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
20. García Rodríguez LA, Hernández-Díaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 2001; 3: 98-101.
21. García Rodríguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007; 132: 498-506.
22. Hernández-Díaz S, García Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-2099.
23. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
24. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984; 79: 516-524.
25. Robins JM, Rotnitzky A, Zhao LP. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc 1994; 89: 846-866.
26. Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health 2006; 60: 578-586.
27. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
28. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In Statistical Models in Epidemiology: The Environment and Clinical Trials, Halloran ME, Berry D (eds.). Springer-Verlag: New York, 1999; 95-134.
29. Jones MP. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc 1996; 91: 222-230.
30. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-694.
31. Raghunathan TE, Lepkowski JM, Van Hoewyk J, et al. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Meth 2001; 27: 85-95.
32. Moons KG, Donders RA, Stijnen T, et al. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006; 59: 1092-1101.
33. Cole SR, Chu H, Greenland S. Multiple-imputation for measurement-error correction. Int J Epidemiol 2006; 35: 1074-1081.
34. Rubin DB. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons: New York, NY, 1987.
35. Sturmer T, Schneeweiss S, Avorn J, et al. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol 2005; 162: 279-289.
36. Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 1989; 8: 1051-1069; discussion 1071-1053.
37. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol 1990; 132: 734-745.
38. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol 1991; 134: 895-907.
39. van der Heijden GJ, Donders AR, Stijnen T, et al. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006; 59: 1102-1109.
40. Knol MJ, Janssen KJ, Donders AR, et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol 2010; 63: 728-736.
41. Little RJA, Rubin DB. Statistical Analysis with Missing Data (2nd Edn). John Wiley & Sons: New York, NY, 2002.
42. Schafer JL. Analysis of Incomplete Multivariate Data. Chapman & Hall: London, UK, 1997.
43. Marston L, Carpenter JR, Walters KR, et al. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf 2010; 19: 618-626.
44. Sturmer T, Schneeweiss S, Rothman KJ, et al. Performance of propensity score calibration-a simulation study. Am J Epidemiol 2007; 165: 1110-1118.
45. Carroll RJ, Ruppert D, Stefanski LA. Measurement Error in Nonlinear Models. Chapman and Hall, Ltd: London, United Kingdom, 1995.
46. Toh S, Hernán MA. Causal inference from longitudinal studies with baseline randomization. Int J Biostat 2008; 4: Article 22.